Legal Representation
Attorney
LUKE P. DE LEON
USPTO Deadlines
Next Deadline
37 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 20, 2025
Extension Available
Until August 20, 2025
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 19, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 18, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Feb 18, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 10, 2024 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS |
| Jul 10, 2024 | OP.D | T | OPPOSITION DISMISSED NO. 999999 |
| Jul 10, 2024 | OP.T | T | OPPOSITION TERMINATED NO. 999999 |
| Nov 28, 2022 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 |
| Jun 30, 2022 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| May 31, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 31, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 11, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 27, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 30, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 29, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 28, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Reagents for scientific, medical research, life science, laboratory, and pharmaceutical research use; chemical preparations for scientific use, namely, for medical research, life science, laboratory, and pharmaceutical research use
Class 005
Reagents and diagnostic reagents for clinical medical use; chemicals for clinical medical use, namely, for diagnosing, detecting, prognosing, stratifying or selecting therapy for a disease condition, including cancer and inherited genetic disorders
Class 009
Instrumentation for scientific, medical research, life science, laboratory, and pharmaceutical research use, namely, flow cytometry analyzers and sorters being flow cytometers for scientific, research, and laboratory use, automated western blot analyzers and western blot imagers being life science laboratory equipment, instruments for capillary electrophoresis being electrophoresis apparatus not for medical purposes, instruments for automated immunoassays being immunoassay analyzers for laboratory use, and instruments for image based particle analysis for scientific, research, and laboratory use
Class 010
Instrumentation for clinical medical and medical diagnostic use, namely, flow cytometry analyzers and sorters being flow cytometers for medical diagnostic use, automated western blot analyzers and western blot imagers for clinical medical and medical diagnostic use, instruments for capillary electrophoresis being electrophoresis apparatus for medical diagnostic purposes, instruments for image-based particle analysis being flow cytometers for medical diagnostic use
Additional Information
Design Mark
The mark consists of stylized letters "bt".
Pseudo Mark
B-T; BIO TECHNE
Pseudo Mark
BIO TECHNE; B-T
Classification
International Classes
001
005
009
010
USPTO Documents
Loading USPTO documents...